Zai Lab (ZLAB), buoyed by a strong start in the first quarter of the 2024, expects to accelerate commercial performance for the remainder of the year.
This research-based, commercial-stage biopharmaceutical company, based in China and the United States, has five marketed products - Zejula, Optune, Qinlock, Nuzyra, and Vyvgart - that have been commercially launched in one or more territories in Greater China.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.